Fundraising for treatment
High-risk neuroblastoma is an aggressive cancer with high rates of relapse. At relapse, the chance of survival is extremely low. Some families affected by high-risk neuroblastoma will choose to fundraise for access to treatment that is not available through the NHS, to try to get their child back into remission, or to try to keep their cancer away. Solving Kids' Cancer UK fully supports parent choice and therefore, helps families with fundraising campaigns for recognised and approved clinical trials or treatments. In the first instance, we always encourage families to discuss their child's treatment with their child's UK consultant.
Treatment options outside of the UK can often cost hundreds of thousands of pounds and raising this level of funds is a huge additional burden on families. This is why supporting families to set up and oversee their fundraising campaign is an important aspect of our support provision. Solving Kids' Cancer UK also helps families with the challenges and logistics of accessing treatment overseas.
If you'd like more information about fundraising campaigns for access to treatment, contact us on 0207 284 0800 or email firstname.lastname@example.org.
Current fundraising campaigns
We are currently supporting a number of children and families to fundraise for access to treatment. Click through to learn more about each child's story and to make a donation.
Donations made to children's fundraising campaigns will go towards supporting the child and family to access treatment and with any pastoral needs. If a child and family no longer needs the funds or a child is in remission five years post the end of successful treatment, the funds will be used to support other children and families affected by neuroblastoma through Solving Kids' Cancer UK's activities. If you'd like more information about fundraising for access to treatment generally, or about any of the children's fundraising campaigns below, contact us on 0207 284 0800 or email email@example.com.
Thank you for supporting children and families!
Rio is a happy, playful and energetic two-year-old who adores cars and spending time with his big sister Lillyrose! In August 2023, Rio was diagnosed with high-risk neuroblastoma.Read more
Leonardo is a five-year-old from London who loves superheroes and motorcycles. In May 2022, Leonardo was diagnosed with high-risk neuroblastoma and he completed frontline treatment in July 2023 but sadly his disease progressed.Read more
Four-year-old Archie loves Hot Wheels and Paw Patrol. In July 2022, Archie was diagnosed with high-risk neuroblastoma. His family are fundraising £154,000 so he can enrol on the DFMO study in Charlotte once he finishes his frontline treatment in October. This trial is currently not available on the NHS.Read more
Bibi's urgent campaign
Bibi’s family are urgently fundraising to raise £200,000 for Bibi to be treated using CAR T cell therapy in Rome with the hope of getting Bibi back into remission again. This trial is currently not available on the NHS.Read more
Teddy is a four-year-old from West Sussex who is obsessed with anything to do with trains! In July 2022, Teddy was diagnosed with high-risk neuroblastoma.Read more
Flora's new campaign
Flora is an energetic, outdoor-loving five-year-old from East Lothian, Scotland. Her family are continuing to fundraise after Flora sadly relapsed in September 2023 and her total now reflects the new campaign fund total.Read more
Arianna is a beautiful, funny and kind-hearted seven-year-old, who loves dressing up! In November 2021, Arianna was diagnosed with high-risk neuroblastoma. Her family are fundraising £300,000 so she can enrol on the bivalent vaccine clinical trial in New York once she finishes frontline treatment in October. This trial is currently not available on the NHS.Read more
Jessica is the sweetest, kindest three-year-old who loves animals, all things Peppa Pig and playing with her cousin, Maeve. Jessica has high-risk neuroblastoma.Read more
Dulcie is a beautiful and brave six-year-old from Shropshire. She loves My Little Pony, all Disney princesses, rainbows and everything that sparkles! Dulcie was diagnosed with high-risk neuroblastoma in December 2021.Read more
Kayla is a very happy and lively five-year-old from Norwich. She loves Minnie Mouse, Frozen, Peppa Pig and all things pink! Kayla was diagnosed with high-risk neuroblastoma and in November 2022, her end of treatment scans showed disease progression.Read more
Eden is full of life, very cheeky and loved by so many people. Eden is currently enrolled on the bivalent vaccine clinical trial in New York, thanks to an incredible community of support for Eden’s campaign.Read more
Maysaa is five years old and loves strawberries, unicorns and rainbows. Maysaa enrolled on the DFMO study in Charlotte in August 2022 to continue her treatment, which was made possible by the community of supporters who helped raise the £106,000 needed.Read more
12-year-old Peter is a keen gamer and loves all things Lego and playing Minecraft. Since January 2022, he has been enrolled on the DFMO study in Charlotte, made possible thanks to an incredible community of support for his campaign.Read more
Seven-year-old Poppy loves playing in the park with her friends and her brother. Poppy completed her frontline treatment in October 2022 and scans continue to show no evidence of active disease.Read more
Ashlee is 16 years old and loves music, fashion and her dog, Angel. Ashlee completed the bivalent vaccine clinical trial in December 2021, thanks to the amazing support her campaign received to raise the £239,000 needed.Read more
Katie Rose's campaign
Katie Rose is a fun-loving, quick-witted, brave 12-year-old girl, who loves making slime, playing Fortnite on her PlayStation, Roblox and Toca Life World and jumping on her trampoline. In March 2018, Katie Rose was diagnosed with high-risk neuroblastoma.Read more
Oliver is described by his dad as the ‘happiest, most fun-loving boy you can imagine – a real joy to be around’. Oliver enrolled on the bivalent vaccine clinical trial in New York in February 2019.Read more
Mikey is seven years old and loves all things dinosaur-related and playing with his little brother, Bobby. Mikey completed the bivalent vaccine clinical trial at Memorial Sloan Kettering Cancer Center in April 2020.Read more